Changes in HER2 status and survival outcomes in patients with non-pathological complete response after neoadjuvant targeted treatment

To study the changes in human epidermal growth factor receptor 2 (HER2) expression in patients with HER2-positive breast cancer before and after neoadjuvant treatment. The clinicopathologic data of 499 patients with HER2-positive breast cancer who completed neoadjuvant treatment and surgery at the F...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Xiaofei, Zhang, Xiangmei, Ma, Xiangmin, Yang, Chao, Li, Jingping, Liu, Beichen, Shi, Chao, Liu, Yunjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5750
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545330/
https://www.ncbi.nlm.nih.gov/pubmed/37773875
http://dx.doi.org/10.1097/MD.0000000000034903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545330/
https://www.ncbi.nlm.nih.gov/pubmed/37773875
http://dx.doi.org/10.1097/MD.0000000000034903

Ejemplares similares